GlassScriptPhysician profile
Ankur Sinha
NPI 1205218369
$11,048.68
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.27 · 2021: $78.99 · 2022: $1,128 · 2023: $9,137 · 2024: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,180 · Travel and Lodging: $2,003 · Food and Beverage: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,179.98 |
| Travel and Lodging | $2,003.39 |
| Food and Beverage | $1,586.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,253.94 | 2022-2023 | Da Vinci Surgical System, Ion |
| Pulmonx Corporation | $1,637.31 | 2022-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $406.25 | 2020-2024 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $261.84 | 2022-2024 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $243.23 | 2023-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $219.78 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.74 | 2022-2024 | Ofev, Stiolto Respimat |
| Steris Corporation | $179.72 | 2024 | |
| Mallinckrodt Hospital Products INC. | $119.39 | 2023 | Acthar |
| Astellas Pharma US INC | $78.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.54 | 2022-2024 | Glassia |
| Olympus America INC. | $59.04 | 2024 | Single-Use Flexible Video Bronchoscope |
| Ethicon INC. | $52.03 | 2022 | |
| Glaxosmithkline, LLC. | $42.30 | 2023-2024 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $37.11 | 2023-2024 | Arikayce |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $36.44 | 2023 | Tezspire |
| Pharming Healthcare, INC. | $28.52 | 2024 | Ruconest |
| Mylan Specialty L.P. | $25.77 | 2022 | |
| Merck Sharp & Dohme LLC | $22.52 | 2024 | Keytruda |
| Grifols USA, LLC | $22.37 | 2023 | Prolastin-C Liquid |
| Philips North America LLC | $18.05 | 2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $13.96 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $12.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.